Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bao Jin Chen Fei Granules
- Development stage
- Unknown
- Lead developer
- Henan University of Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Bao Jin Chen Fei Granules is a traditional Chinese medicine (TCM) compound formulation developed by the Henan University of Traditional Chinese Medicine for the treatment of Coal Worker's Pneumoconiosis (CWP). It is specifically designed to treat patients presenting with the TCM "syndrome of pulmonary qi deficiency." The formulation is manufactured as granules by Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd. and is administered orally. In clinical research, it is evaluated for its potential to improve clinical efficacy and respiratory function when used in combination with standard symptomatic treatments for pneumoconiosis.
- Other names
- Bao Jin Chen Fei
Beyond the preview
Go deeper on Bao Jin Chen Fei Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bao Jin Chen Fei Granules.